For citations:
Usikova E.V., Kaplanov K.D., Vorob'ev V.I., Lobanova T.I., Ul'yanova M.A., Kisilichina D.G., Kobzev Yu.N., Shikhbabaeva D.I., Vinogradova O.Yu., Ptushkin V.V. Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 2022;12(6):64-77. (In Russ.) https://doi.org/10.20340/vmi-rvz.2022.6.CLIN.5